Tendencias21

New idea for targeting the common cancer protein KRAS

Patients with cancers driven by the protein KRAS, which are particularly hard to treat, may benefit from small molecules that attach to and disrupt the function of a KRAS-containing protein complex, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

Fuente : http://www.eurekalert.org/pub_releases/2013-10/aaf…

RedacciónT21

Hacer un comentario